Shree Ganesh Bio-Tech (India) Limited (BOM:539470)
India · Delayed Price · Currency is INR 0.8300
0.00 (0.00%)
At close: Jul 15, 2025
BOM:539470 Revenue
In the fiscal year ending March 31, 2025, Shree Ganesh Bio-Tech (India) had annual revenue of 229.58M INR with 13.22% growth. Shree Ganesh Bio-Tech (India) had revenue of 30.06M in the quarter ending March 31, 2025, a decrease of -20.55%.
Revenue
229.58M
Revenue Growth
+13.22%
P/S Ratio
1.41
Revenue / Employee
n/a
Employees
5
Market Cap
322.89M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 229.58M | 26.80M | 13.22% |
| Mar 31, 2024 | 202.78M | -421.77M | -67.53% |
| Mar 31, 2023 | 624.55M | -101.90M | -14.03% |
| Mar 31, 2022 | 726.44M | 554.30M | 322.01% |
| Mar 31, 2021 | 172.14M | 147.41M | 596.07% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,882.72B |
| HDFC Bank | 2,736.06B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |